Sign inJoin waitlistJoin the waitlist

Doris Quon

Medical Director, Orthopaedic Hemophilia Treatment Center · Centers for Inherited Blood Disorders

Credentials: · · · ·

History

Orthopaedic Hemophilia Treatment Center · Centers for Inherited Blood Disorders
Present

Hematology and Medical Oncology
Ronald Reagan UCLA Medical Center
1999–2003
Internal Medicine
1996–1999
David Geffen Sch of Med at UCLA
1992–1996

Research

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A
New England Journal of Medicine · 2022 · 358 citations
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
New England Journal of Medicine · 2023 · 303 citations
A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management
Journal of Thrombosis and Haemostasis · 2012 · 211 citations

Annette Von Drygalski
17 papers
Michael Wang
14 papers
RK
Rebecca Kruse-Jarres
14 papers
Miguel Escobar
11 papers
AS
Amy Shapiro
8 papers
Craig Kessler
8 papers
MR
Michael Recht
8 papers · 4 as a fellow
Steven Pipe
8 papers
Andrew Leavitt
7 papers
MR
Margaret Ragni
7 papers
Mark Reding
7 papers
Nigel Key
7 papers

Clinical trials

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Site PI · Recruiting · Phase 4
American Thrombosis and Hemostasis Network
2021–2027
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Site PI · Recruiting
American Thrombosis and Hemostasis Network
2020–2035
Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A
Site PI · Unknown · Phase 3
Green Cross Corporation
2013–2015
Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors
Sub-investigator · Recruiting · Phase 2
Sarcoma Oncology Research Center, LLC
2026–2029